A resolution expressing support for the designation of November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month".

Bill 117 S.Res. 792 is a resolution that expresses support for the designation of November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month." Alpha-1 Antitrypsin Deficiency is a genetic disorder that can lead to lung and liver disease. The resolution aims to raise awareness about this condition and the importance of early detection and treatment.

The resolution highlights the impact of Alpha-1 Antitrypsin Deficiency on individuals and families, as well as the need for increased research and resources to support those affected by the disorder. It also recognizes the efforts of organizations and advocates working to raise awareness and improve outcomes for individuals with Alpha-1 Antitrypsin Deficiency.

By designating November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month," the resolution seeks to educate the public, healthcare professionals, and policymakers about this often overlooked condition. It emphasizes the importance of early diagnosis, access to treatment, and support for individuals living with Alpha-1 Antitrypsin Deficiency. Overall, Bill 117 S.Res. 792 aims to bring attention to Alpha-1 Antitrypsin Deficiency and advocate for increased awareness, research, and support for individuals affected by this genetic disorder.